The report "3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free) by Application (Cancer Research, Stem Cell Technology, Primary Cell Research, Tissue Engineering & Regenerative Medicines, Human Cell Lines, Tumor Xenografting, Drug Discovery, and Others) by End-Users (Research Laboratories, Biotechnology and Pharmaceuticals Industries, Hospitals and Diagnostics Centers and Others) - Global Forecast to 2021", analyzes and segments the market on the basis of technology, product, application, and region.
The global 3D cell culture market size is expected to reach USD 1345.2 Million by 2021, at a CAGR of 23.6% during the forecast period of 2016 to 2021.
Browse 66 market data tables with 72 figures spread through 158 pages and in-depth TOC on "3D Cell Culture Market”
On the basis of technology, the 3D cell culture market is segmented into scaffold-based and scaffold free. The scaffold-based segment is further categorized into hydrogels/ECM analogs, solid scaffolds, micropatterned surfaces, and others. Scaffold free segment is further classified into attachment resistant surfaces and suspension cultures. Scaffold-based segment is expected to account for the largest share of the global market in 2016. Due to the variety of material and structural choices for scaffold, they are widely used in various applications in the market. Also, as they provide a surface on which the cells can grow, they can easily impart 3D growth with little alteration to cell culture procedures.
On the basis of type of application, the 3D cell culture market is segmented into cell-based assays/toxicity screening, cancer cell research, 3D printing/microfluidics, regenerative medicine, and in vivo applications for stem cell. The cancer cell research segment is expected to account for the largest share of this market. The rising incidences of cancer have created a need for conducting research to develop new treatment options. As cell culture techniques are used in the R&D and production of vaccines, drugs, therapeutics, and antibiotics, this factor can be expected to drive the market for 3D cell culture.
End users of the 3D cell culture market are research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The biotechnology & pharmaceutical industries segment is expected to account for the largest share of the global market in 2016. The rising incidences of cancer has created a need for advanced drugs and therapies, thus leading for the largest share of this segment.
Get The PDF Brochure For This Report:
Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing government support in the form of grants and funding, rising incidences of cancer, expanding biopharmaceutical industry, and launch of new products in the market.
Scope of the Report:
This report categorizes the 3D cell culture market into the following segments:
- 3D Cell Culture Market, By Technology
- 3D Cell Culture Market, By Application
- 3D Cell Culture Market, By End User
- 3D Cell Culture Market, By Region
- Company Information: Detailed company profiles of five or more market players
- Opportunities Assessment: A detailed report underlining the various growth opportunities in the market
Request a sample of the report:
- Pharmaceutical and Biopharmaceutical Companies
- Manufacturers of Cell Culture Equipment
- Contract Research Organizations
- Life Science Research Institutes
- Venture Capitalists
- Research and Consulting Firms
The prominent players in the 3D cell culture market include 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States